Azacitidine and CAPOX in Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
The goal of the Phase I portion of this study is to find the highest tolerable dose of
azacitidine combined with capecitabine and oxaliplatin (CAPOX) that can be given to patients
with metastatic colorectal cancer.
The goal of the Phase II portion of this study is to learn if azacitidine, given in
combination with CAPOX, can help to control metastatic colorectal cancer. The safety of this
drug combination will also be studied.